-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DdVQfeUNkjcIXv+U5X8FLa2388CrSydIwd85dl2RsBFgAnt+rVZ3N7jKqzNgTKTf 4HKGm5BvDoIR8ouhEsnnZA== 0000922423-06-001547.txt : 20061211 0000922423-06-001547.hdr.sgml : 20061211 20061211164524 ACCESSION NUMBER: 0000922423-06-001547 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20061211 DATE AS OF CHANGE: 20061211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ANGIODYNAMICS INC CENTRAL INDEX KEY: 0001275187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 113146460 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80098 FILM NUMBER: 061268933 BUSINESS ADDRESS: STREET 1: 603 QUEENSBURY AVE CITY: QUEENSBURY STATE: NY ZIP: 12804 BUSINESS PHONE: 5187981215 MAIL ADDRESS: STREET 1: 603 QUEENSBURY AVE CITY: QUEENSBURY STATE: NY ZIP: 12804 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GILDER GAGNON HOWE & CO LLC CENTRAL INDEX KEY: 0000902464 IRS NUMBER: 133174112 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1775 BROADWAY STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127652500 MAIL ADDRESS: STREET 1: 1775 BROADWAY STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GILDER GAGNON HOWE & CO DATE OF NAME CHANGE: 19930428 SC 13G/A 1 kl12018.htm SCHEDULE 13G AMENDMENT NO.1 Schedule 13G Amendment No.1



SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
                   
 
Under the Securities Exchange Act of 1934
 
SCHEDULE 13G
Amendment No. 1

INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
     AngioDynamics, Inc.    
(Name of Issuer)
 
         Common Stock         
(Title of Class of Securities)
 
         03475V101         
(CUSIP Number)
 
                        November 30, 2006                      
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
ý Rule 13d-1(b)
¨ Rule 13d-1(c)
¨ Rule 13d-1(d)
 
                   
 
Page 1 of 6 Pages





SCHEDULE 13G
 
CUSIP No. 03475V101                                                                                    Page 2 of 6 Pages
 
 
1)
 
 
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
 
Gilder, Gagnon, Howe & Co. LLC
13-3174112
 
 
2)
 
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
(a) o
(b) o
 
 
3)
 
 
SEC USE ONLY
 
 
4)
 
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
New York
 
 
 
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
 
 
5)
 
 
SOLE VOTING POWER
 
31,175
 
 
6)
 
 
SHARED VOTING POWER
 
None
 
 
7)
 
 
SOLE DISPOSITIVE POWER
 
None
 
 
8)
 
 
SHARED DISPOSITIVE POWER
 
2,524,493
 
 
9)
 
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
2,524,493
 
 
10)
 
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
 
o
 
 
11)
 
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
16.3%
 
 
12)
 
 
TYPE OF REPORTING PERSON
 
BD
 




Schedule 13G
 
Item 1(a).     Name of Issuer:
 
AngioDynamics, Inc.
 
Item 1(b).     Address of Issuer’s Principal Executive Offices:
 
603 Queensbury Avenue
Queensbury, NY 12804

Item 2(a).     Name of Person Filing:

Gilder, Gagnon, Howe & Co. LLC
 
Item 2(b).     Address of Principal Business Office or, if None, Residence:
 
1775 Broadway, 26th Floor
New York, NY 10019
 
Item 2(c).     Citizenship:
 
New York
 
Item 2(d).     Title of Class of Securities:
 
Common Stock
 
Item 2(e).     CUSIP Number:
 
03475V101
 
Item 3.          If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
[x]
Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o)
 
 
(b)
¨
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)
 
 
(c)
¨
Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
 
 
(d)
¨
Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
 
 
(e)
¨
Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E)
 
 
(f)
¨
Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F)
 
 
(g)
¨
Parent Holding Company or control person in accordance with §240.13d-1(b)(ii)(G)
 
 
 

 
 
 
(h)
¨
Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
 
 
(i)
¨
Church plan that is excluded from the definition of an investment company under §3(c)(15) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
 
 
(j)
¨
Group, in accordance with §240.13d-1(b)(ii)(J)
 
Item 4.          Ownership.
 
 
(a)
 
Amount beneficially owned: 2,524,493
 
 
(b)
 
Percent of class: 16.3%
 
 
(c)
 
Number of shares as to which such person has:
 
 
(i)
Sole power to vote or to direct the vote: 31,175
 
 
(ii)
Shared power to vote or to direct the vote: None
 
 
(iii)
Sole power to dispose or to direct the disposition of: None
 
 
(iv)
Shared power to dispose or to direct the disposition of: 2,524,493
 
               The shares reported include 2,086,285 shares held in customer accounts over which partners and/or employees of the Reporting Person have discretionary authority to dispose of or direct the disposition of the shares, 407,033 shares held in accounts owned by the partners of the Reporting Person and their families, and 31,175 shares held in the account of the profit-sharing plan of the Reporting Person (“the Profit-Sharing Plan”).
 
Item 5.          Ownership of Five Percent or Less of a Class.
 
Not applicable

Item 6.          Ownership of More than Five Percent on Behalf of Another Person.

The owners of the accounts (including the Profit-Sharing Plan) in which the shares reported on this Schedule are held have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities.

Item 7.          Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable
 

 


Item 8.          Identification and Classification of Members of the Group.
 
Not applicable
 
Item 9.          Notice of Dissolution of Group.
 
Not applicable
 
Item 10.       Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect.
 

 


 
SIGNATURE
 
After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct.
 
  December 11, 2006                            
Date
 
  /s/ Walter Weadock                         
Signature
 
  Walter Weadock, Member              
Name/Title
 
 
 
 
 
 
 
-----END PRIVACY-ENHANCED MESSAGE-----